5th International Conference On Central Nervous System Disorders & Therapeutics

Theme: Gaining Critical Insights in CNS And Therapeutics

Event Date & Time

Event Location

Las Vegas, USA

18 years of lifescience communication

Performers / Professionals From Around The Globe

Conference Speaker

Myung Koo Lee

Chungbuk National University, South Korea

Conference Speaker

Chethan P. V. Rao

Program Director Baylor College of Medicine, USA

Conference Speaker

Pankaj Sharma

Imperial College London, UK

Conference Speaker

Thomas Eko Purwata

Sanglah Hospital - Udayana University, Indonesia

Conference Speaker

Wai Kwong Tang

Chinese University of Hong Kong, Hong Kong
Hong Kong

Conference Speaker

Jyri Kussela

NeuroVitalia and Ataman Science, Spain

Conference Speaker

Peter Silburn

The University of Queensland, Australia

Conference Speaker

Giovanni Antioco Putzu

Casa di Cura Sant’Elena, Italy

Conference Speaker

O. Nuri Ozgirgin

Professor Bayindir Hospital, Turkey

Conference Speaker

Xi Huang

Nanjing University of Chinese Medicine, China

Conference Speaker

Wolfram Kersten

Mind-up GmbH & CO.KG – Bamberg, Germany

Conference Speaker

Goang Won Cho

Chosun University, South Korea
South Korea

Tracks & Key Topics

CNS Conference 2019


We invite all the participants/members from all over the world to attend the Neurology conference entitled 5th International Conference on Central Nervous System Disorders and Therapeutics which is going to be held during October 21-22, 2019 | Lasvegas, USA

The main theme of our conference is "Accelerate the Diagnosis, Prevention & Management of CNS Disorders" which covers a wide range of critically important sessions.

Overview of CNS Disorders:

Central nervous system disorders can influence either the spinal line (myelopathy) or brain (encephalopathy), both of which are a piece of the CNS. The nervous system is defenceless against different diseases. It can be harmed by the accompanying Trauma, contaminations, bloodstream interruption, tumors, immune system issue and so forth. Disorders of the CNS may include the accompanying:

  •  Vascular Disorders: Stroke, Transient ischemic assault (TIA), Subarachnoid discharge, Subdural drain and Hematoma, and Extradural drain
  •  Infections: Meningitis, Encephalitis, and epidural ulcer
  • Structural Disorders: Brain or Spinal line damage, Bell's paralysis, cervical spondylosis, Carpal passage disorder, Brain or Spinal rope tumors
  • Functional Disorders: A migraine, Epilepsy, Dizziness, and Neuralgia
  • Degenerative Disorders: Parkinson disease, Multiple sclerosis, Amyotrophic Lateral Sclerosis (ALS), Huntington chorea, and Alzheimer disease.

Furthermore, the geological dispersion of CNS disorders and market over the US, the main five nations of Europe and in Japan. The report likewise incorporates bits of knowledge into the CNS disease R&D item pipeline and investigates the focused scene incorporating significant players in CNS illness advertise. At last, the report additionally incorporates investigation of Mergers and Acquisitions (M&As) and permitting assentions that occurred in CNS disorders therapeutics showcase.

With a specific end goal to quicken the exploration in the field of Neuroscience and Neurology, ConferenceSeries Ltd composes diverse meeting arrangement around the world.

Why to attend?

CNS 2019 aims to unite overall recognized scholastics in the field of Neuro-oncologist, Neuro-pharmacologists, Neurologists, Neuropediatrics, Pediatric Oncologists, Neurosurgeons, Neurophysiologists, Neuroscience Brain analysts, Public Health experts, Scientists, Academic researchers, Industry specialists, Scholars to trade about best in class Research and Technologies and to convey revelations of CNS diseases to Patients. Attending international conference is for the Professional Development and to comprehend the momentum condition of research and the difficulties to future disclosure.

The primary moto of the CNS Conference is to give a stage to academicians and experts from numerous controls to banter about and ponder on social change that is incorporated by development and innovation.

Target Audience

Directors, Head of Department, Professors, Industrial Researchers, Neuro-oncologist, Neuropediatricians, Neurophysiologists, Neurosurgeons, Neurologist, Neuroradiologist, Neuro-Pathologists, Rehabilitation Specialists ,  Nurses, Neuroscience Researchers and Students from academia  in the research of CNS Disorders and Neurology.

Academia: 65%

Industry: 25%

Others: 10%

A Unique Opportunity for Advertisers and Sponsors at this International event



session and tracks

It's our pleasure to welcome every one of the members from everywhere throughout the world to go to the 5th International Conference on Central Nervous System Disorders and Therapeutics which is held at mid October 21-22, 2019| Lasvegas, USA

The primary topic of our Conference is "Accelerate the Diagnosis, Prevention & Management of CNS Disorders" which covers an extensive variety of basically essential sessions.

CNS disorders can influence either the mind or the spinal line, bringing about neurological or mental issues. Reasons for focal sensory system maladies are injury, diseases, degeneration, immune system issue, auxiliary deformities, tumors, and stroke.

Track 1: Central Nervous System Disorders

The Central Nervous System has hundred billions of neurons which work by tolerating, engendering and transmitting electrochemical driving forces. Neurobiology manages useful human neuroanatomy and neurophysiology of cerebrum, spinal rope, white and dim issue, cerebrospinal liquid, synaptic and circuit elements.

Track 2: Neuropsychiatry

Neuropsychiatry is a branch of medication that arrangements with mental scatters owing to ailments of the sensory system. It went before the present orders of psychiatry and neurology, which had basic preparing, be that as it may, psychiatry and neurology are in this way split separated and are regularly rehearsed independently. All things considered, neuropsychiatry has turned into a developing subspecialty of psychiatry and it is additionally firmly identified with the fields of neuropsychology and behavioral neurology.

Track 3: Cerebral Disorders

Cerebral dysfunction might be focal or worldwide. Central brokenness is caused by auxiliary irregularities and worldwide brokenness is caused by harmful metabolic issue and diffuses irritation, vasculopathy, significant injury, or spread tumor; these maladies influence various measurements of cerebral capacity.

Consistently, an expected 30,000 individuals in the United States encounter a burst cerebral aneurysm and upwards of 6 percent may have an un-cracked aneurysm.

Track 4: Neuronal Disorders

Neuronal Disorders might be characterized as disarranges of the BrainSpine and nerves that interface them. For instance: Alzheimer's disease (AD) EpilepsyMultiple sclerosis and so on.

As per World Health Organization report-different sorts of neurodegenerative issue influence a huge number of individuals around the globe, including 25 million that experience the ill effects of Parkinson disease and 327 million who encounter cerebral pains and headaches.

Track 5: Cognitive Neurology

Cognitive neurology is a logical investigation of neural system basic discernment. It is worried about the determination and treatment of infections that influence memory and other 'subjective' resources, (for example, dialect, discernment, arranging capacity and social comportment). Intellectual neuroscience is at the crossing point of brain research and neuroscience, yet it likewise covers with physiological brain research, neuropsychology and subjective brain science. This joins the speculations of subjective brain research and


Track 6: Brain Tumors and Neuro Surgery

Neurosurgery might be characterized as the surgical claim to fame that is worried about the analysis and surgical treatment of the CNS and Peripheral Nervous System. It is otherwise called Neurological Surgery. It is performed by a doctor called neurosurgeon. In light of nature of scatters or infections, neurosurgeons give agent and non-agent mind. It treats patients with mind tumor, head and spinal string damage.

Sorts of Neurosurgery include: I). Endovascular Neurosurgery, II). Oncological Neurosurgery III). Stereotactic Neurosurgery so on.

Track 7: Spine Surgery and Spinal Disorders

The spinal cord alludes as the primary pathway for data interfacing/exchanging to the brain and fringe sensory system. The spinal string is otherwise called the extensive gathering of nerves which goes through the focal point of the spinal cord and conveys messages between the mind and the whole body. The spinal disorders might be found in people independent of their age-Chiari mutation in new born children to spinal stenosis in the elderly. The expansion in the populace with spinal sicknesses has met with a jump in the headways in analytic and treatment procedures. The ordinarily utilized instruments in diagnosing spinal diseases are as per the following: X beams, MRI, CT and DEA and so on.

Track 8: Neuroinfections & Neuroimmunological disorders

Neuroimmunology is an investigation of sensory system and immunology and its issue is insusceptible framework related sensory system (focal or fringe) sicknesses. Distinctive sorts of collaborations are engaged with both the apprehensive and insusceptible frameworks yet not restricted to the physiological working of the frameworks that prompt issue and the synthetic, physical and natural stressors.

Track 9: Neurochemical Transmission

A Neuron conveys its electrical action to different cells by discharging chemicals at the Junction of the two cells, that procedure is known as Neurochemical transmission. The compound substances which exchange an electrical motivation from a nerve cell to its objective cell are known as neurotransmitters.


Track 10: Neurogenetics & Neurometabolic disorders

Neurogenesis characterizes the procedure by which neurons are produced from neural undeveloped cells and ancestor cells. A wide range of assortments of excitatory and inhibitory neurons are produced from various types of neural undifferentiated cells. The sub-atomic and hereditary components affecting beginning of neuron prominently incorporate the Notch Signaling pathway, and numerous qualities have been connected to Notch Signaling pathway direction. It has been found to happen in two mind locales: the subventricular zone and the hippocampus.

Track 11: Neuro Oncology and CNS

Neuro-oncology characterizes the investigation of mind and spinal string neoplasms, a significant number of which are exceptionally hazardous and dangerous. For instance: glioma, glioblastoma multiforme, ependymoma, pontine glioma, and mind stem tumors and so forth. Most Commonly utilized medications in neuro-oncology are Radiotherapy, Chemotherapy, Corticosteroids and Neurosurgical Interventions.

Track 12: Clinical Trials & Case Reports in CNS

With a consistently expanding normal future, Neurological and CNS Disorders are ending up more common in the public arena. The financial and social expenses of Neurological and CNS Disorders to society are tremendous. Numerous huge pharmaceutical organizations have moved far from CNS and Neurology look into.

 This meeting will give designates a chance to increase extra information and experiences into the accepted procedures in clinical trials, and additionally tending to the difficulties in CNS and Neurology explore and by taking a gander at the most recent preclinical and clinical investigations.

Track 13: CNS Biomarkers

CNS Biomarkers are utilized as a part of clinical research and in clinical practice as a quantifiable marker of an ordinary neurological condition, sick state or pharmacologic reaction to a remedial intercession. CNS biomarkers incorporate neuroimaging biomarkers, CSF biomarkers, and the part of biomarkers in determination and medication improvement.

Track 14: Neuroplasticity & Neurorehabilitation

The field of neurorehabilitation is generally new, and some bleeding edge treatments, including neuromodulation, that might be possibly useful topatients with CNS wounds or a different issue, are presently being examined. The advances in the comprehension of mind hardware, together with the improvement of neurostimulation innovations have provoked us to investigate the capability of electrical incitement of the sensory system to advance practical recuperation in patients with CNS disorders. In general, progresses in neuromodulation may offer new helpful intercessions for patients with stroke, horrendous mind damage, spinal cord damage and epilepsy by balance the unusual system in the cerebrum.

Track 15: Neuro Pharmaceutics

Neuro-pharmaceutics considers concentrates on the revelation of remedial targets, and after that making an interpretation of those disclosures into medication and treatment improvement. It is the biggest potential development segment of the pharmaceutical business. In any case, this development is obstructed by the issue of the blood-brain barrier.

Track 16: Perspective in Neuroscience and Neurology

The neuroscience viewpoint identifies with the way that individual’s demonstration regarding how they became. It manages the scientific investigation of the nervous system and perceived as the branch of science. Then again, neurology point of view manages the branch of pharmaceutical managing the central nervous system disorders, determination and treatment of all sorts of infections in the focal central nervous system and fringe sensory system.

Track 17: Novel Neurotherapeutics, Diagnostics & Case Studies

The neuroscience point of view identifies with the way that individual’s demonstration as far as how they became. It manages the logical investigation of the sensory system and perceived as the branch of science. Then again, neurology point of view manages the branch of prescription managing the clutters of nervous system, analysis and treatment of all sorts of infections in the focal sensory system and fringe sensory system.



Market Analysis

Industry Insights

The global Central Nervous System (CNS) therapeutic market size was worth USD 77.2 billion in 2016 and is anticipated to grow at a CAGR of 5.9% during the forecast period .Advancements in diagnostics, therapeutics, and drugs discovery techniques are primarily driving the growth of market. Moreover, rising demands for effective therapeutic options are motivating major pharmaceutical’s companies to invest on R&D for the same, thus creating future growth opportunities.  

In addition, growing geriatric population prone to various CNS diseases including Alzheimer ‘s and schizophrenia is expected to fuel the growth .

India CNS therapeutics market, by diseases

Increasing awareness regarding mental health, social acceptance of mentally ill patients, and increasing access to advanced healthcare options are some of the principals factors expected to drive market growth.

Mental health and degenerative disorders segments are major contributors to escalating demand for the global CNS therapeutics. Technical advancement in neurological imaging , which helps in early diagnosis , is a key factor  fuelling growth.

Organizations such as the WHO as well as American Association of Neurological Surgeons conduct various conferences and seminars to increase awareness about mental disorders and their treatments.

Report Coverage & Deliverables

PDF reports and online dashboard will help you understand :

Competitive benchmarking

Market forecasts

Company market shares

Market opportunities

Latest trends & dynamics

Segment insights

Mental health segment dominated the market in 2016 and is expected to continue its dominance throughout the forecast period.

Increasing number of patients with mental disorder, extensive R&D, raising number of rehabilitation facilities, and the introduction of novel treatment procedures are prime factors propelling growth.

Global mental health therapeutics market, by type (%)



Cancer is expected to emerge as the fastest growing segment. This is mainly attributed to increasing mortality due to cancer and rising need for effective treatment. Companies such as Teva pharmaceuticals and Eli Lilly and company are focusing on manufacturing drugs that can help reduce pain associated with CNS cancers.

Neurovascular diseases & mental health segment is gaining pace due to increasing awareness and social acceptance of patients. An increasing number of rehabilitation centres along with campaigns to increase awareness and assist mental patients to adjust in society, has led to increase in the number of patients seeking treatment for mental conditions.

The progress of each segment depends on the availability of skilled professionals, hospitalization facilities, and therapy with effective counselling.

Regional Insights

North America dominated the market by capturing the largest share in 2016. This can be attributed to factors such as rising number of reported cases of depression & anxiety and high adoption of advanced therapeutics.

Asia Pacific is expected to exhibit highest growth rate due to high prevalence of neurodegenerative diseases, rapidly increasing awareness regarding mental health, and improving healthcare facilities.

India and china are the countries that have several nongovernment organizations that offer affordable treatments to people with Alzheimer’s and Parkinson’s disease.

Middle East and Africa is expected to experience lucrative growth with increasing access to advanced therapeutic options owing to initiatives by United Nations Programme on HIV/AIDS .

Competitive Market Share Insights:

Companies currently dominating the market are Pfizer, Inc.; Biogenic, Inc.; Johnson & Johnson Services, Inc.; Eli Lilly and Company; Otsuka America Pharmaceutical, Inc.; Merck & Co., Inc.; AstraZeneca; Novartis AG; Teva Pharmaceutical Industries Ltd.; and Shire Plc. These players are investing heavily on R&D to create a strong pipeline of drugs aimed at delivering improved patient care at low costs.

The companies that have more majorities adopt few strategies such as development of advanced diagnostic methods to increase success rate of treatment and regional expansion

Report Scope :




Base year for estimation


2014 - 2015

Forecast period

2017 - 2025


Market representation

The Revenue in the form of USD millions and CAGR is from 2016 to 2025.

Regional scope

Region such as North America, Europe, Asia Pacific, Latin America, Middle East & Africa.


Country scope

U.S., Canada, U.K., Germany, India, China, Brazil, Mexico, South Africa.

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific market information, we will provide it to you as a part of customization.


Segments Covered in the Report:

This report gives the details of growth at at global, regional, & country levels as well as provides an analysis on the latest trends and opportunities in each of the sub-segments from 2016 to 2025.

Disease Outlook (Revenue, USD Million, 2016 - 2025)

. Neurovascular Disease

. Trauma

. Mental Health

   Anxiety Disorders

   Mood Disorders

. Degenerative

   Alzheimer's disease

   Parkinson’s disease

   Multiple Sclerosis


Regional Outlook (Revenue, USD Million, 2016 - 2025)

. North America



 . Europe



. Asia Pacific



. Latin America




  South Africa




Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker


A huge thanks to all our amazing partners. We couldn’t have a conference without you!